Rule 1: Molecules that contain a nitro group (-NO2) are likely to cause adverse effects related to skin and subcutaneous tissue disorders.
Rule 2: Molecules with a halogen atom such as fluorine, chlorine or bromine likely cause adverse effects related to skin and subcutaneous tissue disorders.
Rule 3: Molecules that contain a carbonyl group (-C=O) are likely to cause adverse effects related to skin and subcutaneous tissue disorders.
Rule 4: Presence of a phenyl group (C6H5) in a molecule increases the likelihood of adverse effects related to skin and subcutaneous tissue disorders.
Rule 5: Existence of a functional group, known to cause other adverse effects in a molecule, can also cause skin and subcutaneous tissue disorders.
Rule 6: Molecules containing multiple functional groups can cause severe adverse effects.
Rule 7: Presence of a chlorine atom (-Cl) in a molecule can cause adverse effects related to skin and subcutaneous tissue disorders.
Rule 8: Presence of a hydroxyl group (-OH) in a molecule increases the likelihood of causing adverse effects.
Rule 9: Molecules containing a sulfonamide group are likely to cause adverse effects related to skin and subcutaneous tissue disorders.
Rule 10: Molecules having a quinolone group are likely to have side effects related to skin and subcutaneous tissue disorders.
Rule 11: Molecules with multiple functional groups known for causing adverse effects are likely to produce a more severe adverse effect.
Rule 12: Molecules with a functional group like an amide, imide, or urea have a tendency of causing adverse effects related to skin and subcutaneous tissue disorders.
Rule 13: Molecules that contain a halogenated aromatic ring can cause adverse effects related to skin and subcutaneous tissue disorders.
Rule 14: Molecules containing a polar functional group or a ring structure can cause adverse effects.
Rule 15: Molecules that contain a polycyclic aromatic hydrocarbon (PAH) structure have a higher rate of causing adverse effects related to skin and subcutaneous tissue disorders.
Rule 16: Molecules containing functional groups known for causing gastrointestinal or respiratory disorders are more likely to cause adverse effects. 
Rule 17: Presence of a benzene ring in a molecule increases the likelihood of causing adverse effects.
Rule 18: Molecules with a high lipophilicity or high molecular weight have a higher tendency of causing adverse effects.
Rule 19: Molecules that contain a carboxylic acid group (-COOH) are more likely to cause adverse effects related to skin and subcutaneous tissue disorders.
Rule 20: High lipophilic (hydrophobic) molecules have a tendency to cause adverse effects.
Rule 1: Molecules with functional groups known to cause skin and subcutaneous tissue disorders are likely to cause adverse effects. 

Rule 2: Molecules with ring structures are less likely to cause adverse effects.

Rule 3: Molecules with polar functional groups are more likely to cause adverse effects.

Rule 4: Molecules containing a chlorine atom are predicted to cause adverse effects due to their potential to cause skin and subcutaneous tissue disorders.

Rule 5: Molecules that do not contain any functional groups known to cause skin and subcutaneous tissue disorders are less likely to cause adverse effects.

Rule 6: Molecules containing a carbonyl group are predicted to cause adverse effects due to their potential to cause skin and subcutaneous tissue disorders.

Rule 7: Molecules containing a hydroxyl group are predicted to cause adverse effects due to their potential to cause skin and subcutaneous tissue disorders.

Rule 8: Molecules containing a nitrogen atom are predicted to cause adverse effects due to their potential to cause skin and subcutaneous tissue disorders.

Rule 9: Molecules containing a nitro group are likely to cause adverse effects related to skin and subcutaneous tissue disorders.

Rule 10: Molecules containing a halogen atom (F, Cl, Br, or I) are likely to cause adverse effects related to skin and subcutaneous tissue disorders.
